Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    11744833 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment
Conditions: Tuberculosis;   Human Immunodeficiency Virus Infections
Interventions: Drug: Didanosine, Lamivudine, Efavirenz;   Drug: Didanosine, Lamivudine, Nevirapine

Study has passed its completion date and status has not been verified in more than two years.